SanMelix Laboratories Wins Stevie® Award in 2021 American Business Awards® for its BEECure™ Line
Judge refers to SanMelix as “Leader in bioactive wound dressings, interesting approach, and promising research.”
HOLLYWOOD, Fla.--(BUSINESS WIRE)-- SanMelix Laboratories, Inc. was named winner of a Stevie® Award in Health & Pharmaceuticals - Product, in The 19th Annual American Business Awards® for its line of BEECure™ products.
BEECure utilizes bioactive medicinal properties of buckwheat honey for treatment of advanced and minor wound care for trauma victims, burns, diabetes and cancer patients undergoing radiation and laser therapy.
More than 250 professionals worldwide participated in the judging to select this year’s Stevie Award winners from more than 3,800 nominations. Judges’ comments include: “Great innovation in wound care,” and “A novel approach to the dressing of acute and chronic wounds, SanMelix brings to the world a solution that considers the adverse impact of pharmaceutical treatments while applying an understanding of natural healing methods. The simplicity and power of this solution is hard to look past.”
Founded by Harvard-trained surgeon Dr. Kenneth A. Sabacinski, involved in medical and surgical treatment of limb-threatening and chronic wounds for over 30 years, SanMelix is partially funded by 1,700 investors via StartEngine equity crowdfunding. A new campaign will begin in 2021. The company’s first product, BEECure R, is available on Amazon and Walmart.com. BEECure M and BEECure BH, advanced wound care dressings, are presently undergoing FDA regulatory submission.
“We are honored to have received this award and thrilled by the overwhelmingly positive reception of our BEECure products,” said SanMelix co-founder Diana Sabacinski, CPA, Chief Executive Officer/President (Director). “The great strides we have made as a company over the last three years--including over $1,000,000 in funding--are a testament to the power of our operating philosophy; and we believe we are uniquely positioned to win in a vast and underserved market.”
SanMelix Laboratories, Inc. is a bioactive wound care company focusing on the unique medicinal properties of Buckwheat Honey for tissue regeneration and accelerated healing. Its patented BEECure M product has higher anti-inflammatory and anti-oxidant properties than manuka honey-based products as well as higher standardization and broader spectrum anti-microbial activity. Its over-the-counter skin products are designed to help in the healing of minor burns, scrapes, radiodermatitis and more. To learn more about BEECure™ visit www.SanMelixLaboratories.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005754/en/
Suzan French Gennace, 917-284-8523, email@example.com
Source: SanMelix Laboratories, Inc.
View this news release online at: